SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-19-035664
Filing Date
2019-06-14
Accepted
2019-06-14 16:16:10
Documents
8
Period of Report
2019-06-14

Document Format Files

Seq Description Document Type Size
1 6-K a19-11471_16k.htm 6-K 10788
2 EX-99.1 a19-11471_1ex99d1.htm EX-99.1 914910
3 GRAPHIC g114711mm15i001.gif GRAPHIC 1918
4 GRAPHIC g114711mm15i002.gif GRAPHIC 2216
5 GRAPHIC g114711mm15i003.gif GRAPHIC 2229
6 GRAPHIC g114711mm15i004.gif GRAPHIC 2472
7 GRAPHIC g114711mm15i005.gif GRAPHIC 1988
8 GRAPHIC g114711mm15i006.jpg GRAPHIC 3965
  Complete submission text file 0001104659-19-035664.txt   947979
Mailing Address 245 TALBOT STREET W., SUITE 103 LEAMINGTON A6 N8H 1N8
Business Address 245 TALBOT STREET W., SUITE 103 LEAMINGTON A6 N8H 1N8 (844) 427-4742
Aphria Inc. (Filer) CIK: 0001733418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-38708 | Film No.: 19899081
SIC: 2833 Medicinal Chemicals & Botanical Products